<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

Soft Tissue Fixation Rebounds: Q122 Market Recap

6/22/22 11:10 AM

Q122 Soft Tissue Fixation HEADER copySoft Tissue Fixation Rebounds in Q122

After a slow end to 2021, Soft Tissue Fixation bounced back with procedure volumes rebounding in the first quarter of 2022. With 2021 being a year of ups and downs due to the COVID pandemic, staffing shortages and supply chain issues, the start of 2022 looked to be no different. However, even though the quarter started off a bit sluggish, it picked up steam quickly and ended on a positive note with worldwide Soft Tissue Fixation revenues up +7.5% over Q121.

Among the many topics covered in detail in our comprehensive Q122 Soft Tissue Fixation Market Recap* are:

  • Complete Q122 Soft Tissue Fixation Market Overview
  • SmartTRAK's Expert Analysis and Insights
  • All Market News including Revenues, Data, Charts and Shares
  • Top Competitor Results & Highlights
  • Q122 Clinical/Regulatory Events
While COVID still seemed to be having a negative effect in some areas, it loosened its grip in Q1 overall and was not affecting hospital visits and case cancellations to the amount that it had late in 2021 with the onset of Omicron. Arthroscopy and sports medicine case volumes rebounded in established markets such as ...
 

Read the entire Q122 Soft Tissue Fixation Market Recap, including news, data, charts, company revenues, shares and our expert analysis*

*The entire unedited article and these links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.  Learn More about Subscribing to SmartTRAK


SmartTRAK now offers Skin Substitutes (CTP) Site of Care. This module will make you an expert in Site of Care information for the Skin Substitutes market. Receive market shares, 5-Year Growth Projections and Company & Product Performance across multiple sites of care. Download our PDF to get a preview of what's available! 

Andy Knapik
Written by Andy Knapik

Sr. Analyst, Soft Tissue & Arthroscopic Technologies - 20 years’ experience in US and International sales and marketing for the orthopedics and sports medicine markets, including 12 years at Smith & Nephew.

    Follow Us on Social Media

    Recent Articles